  The loss of neuronal cells in the central nervous system may happen in
numerous neurodegenerative illnesses. Alzheimer's Disease (AD) is an intricate,
irreversible, dynamic neurodegenerative sickness. It is the main source of
age-related dementia, influencing roughly 5.3 million individuals in the United
States alone. Promotion is a typical feeble ailment in individuals more than 65
years, bringing on disability described by decrease in memory, failure to learn
and do every day exercises, intellectual weakness and influences the personal
satisfaction of patients. Pathologic qualities of AD are an irregular
development of specific proteins called Beta-amyloid "plaques" and Tau
"Tangles" in the mind. Notwithstanding, current treatments against AD are just
to calm manifestations and palliative yet are not the cure and a few promising
medications competitors have fizzled in late clinical trials. There is
consequently a critical need to enhance our comprehension for pathogenesis of
this sickness, making new and creative prescient models with powerful
treatments. As of late, stem cell treatment has been appeared to have a
potential way to deal with different illnesses, including neurodegenerative
disorders. In light of the far reaching nature of AD pathology, stem cell
substitution procedures have been seen as an extraordinarily difficult and
impossible treatment approach. Stem Cell may likewise offer an effective new
way to deal with model and concentrate AD. Patient derived induced Pluripotent
Stem Cells (iPSCs), for instance, may propel our comprehension of disease
mechanism. In this review we will examine the capability of stem cells to help
in these testing tries.
